CELCCelcuity Inc.

Healthcare
$70.35-8.8% 1Y

The business

How CELC's business earns

Share count, year on year
+16%

Share count, year on year · more shares than a year ago

Details›
Free cash flow, trailing twelve months
−$213M
Net income, trailing twelve months
−$256M

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.

Biotechnology

The closest names by size in the same industry

Compare peers
VRDN+6.0%
Viridian Therapeutics, Inc.
DYN+3.3%
Dyne Therapeutics, Inc.
TARS+3.4%
Tarsus Pharmaceuticals, Inc.
TLX+2.8%
Telix Pharmaceuticals Limited
ARQT+2.6%
Arcutis Biotherapeutics, Inc.
DNLI+1.5%
Denali Therapeutics Inc.
Celcuity (CELC) Margins and Return on Capital · Ryufin